636 related articles for article (PubMed ID: 19285943)
1. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
[TBL] [Abstract][Full Text] [Related]
2. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.
Baraniak AP; Chen JR; Garcia-Blanco MA
Mol Cell Biol; 2006 Feb; 26(4):1209-22. PubMed ID: 16449636
[TBL] [Abstract][Full Text] [Related]
3. Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
Zhao Y; Li M; Wu W; Miao W; Liu H
Front Immunol; 2023; 14():1161273. PubMed ID: 37090731
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
5. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.
Warzecha CC; Shen S; Xing Y; Carstens RP
RNA Biol; 2009; 6(5):546-62. PubMed ID: 19829082
[TBL] [Abstract][Full Text] [Related]
6. Characterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicing.
Hovhannisyan RH; Warzecha CC; Carstens RP
Nucleic Acids Res; 2006; 34(1):373-85. PubMed ID: 16410617
[TBL] [Abstract][Full Text] [Related]
7. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
8. A Non-sequence-specific double-stranded RNA structural element regulates splicing of two mutually exclusive exons of fibroblast growth factor receptor 2 (FGFR2).
Muh SJ; Hovhannisyan RH; Carstens RP
J Biol Chem; 2002 Dec; 277(51):50143-54. PubMed ID: 12393912
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.
Ranieri D; Belleudi F; Magenta A; Torrisi MR
Int J Cancer; 2015 Jul; 137(1):61-72. PubMed ID: 25450802
[TBL] [Abstract][Full Text] [Related]
10. A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements.
Baraniak AP; Lasda EL; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2003 Dec; 23(24):9327-37. PubMed ID: 14645542
[TBL] [Abstract][Full Text] [Related]
11. Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.
Newman EA; Muh SJ; Hovhannisyan RH; Warzecha CC; Jones RB; McKeehan WL; Carstens RP
RNA; 2006 Jun; 12(6):1129-41. PubMed ID: 16603716
[TBL] [Abstract][Full Text] [Related]
12. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
[TBL] [Abstract][Full Text] [Related]
13. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
14. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
Di Modugno F; Iapicca P; Boudreau A; Mottolese M; Terrenato I; Perracchio L; Carstens RP; Santoni A; Bissell MJ; Nisticò P
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19280-5. PubMed ID: 23129656
[TBL] [Abstract][Full Text] [Related]
15. Ablation of the epithelial-specific splicing factor Esrp1 results in ureteric branching defects and reduced nephron number.
Bebee TW; Sims-Lucas S; Park JW; Bushnell D; Cieply B; Xing Y; Bates CM; Carstens RP
Dev Dyn; 2016 Oct; 245(10):991-1000. PubMed ID: 27404344
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis.
Chen KJ; Li Q; Weng CM; Duan ZX; Zhang DD; Chen ZQ; Chen J; Wang JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30049844
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo.
Somarelli JA; Schaeffer D; Bosma R; Bonano VI; Sohn JW; Kemeny G; Ettyreddy A; Garcia-Blanco MA
RNA; 2013 Jan; 19(1):116-27. PubMed ID: 23185039
[TBL] [Abstract][Full Text] [Related]
18. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol limits epithelial to mesenchymal transition through modulation of KHSRP/hnRNPA1-dependent alternative splicing in mammary gland cells.
Moshiri A; Puppo M; Rossi M; Gherzi R; Briata P
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):291-298. PubMed ID: 28088441
[TBL] [Abstract][Full Text] [Related]
20. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
Cha JY; Lambert QT; Reuther GW; Der CJ
Mol Cancer Res; 2008 Mar; 6(3):435-45. PubMed ID: 18337450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
